B cells and complement at the forefront of chemotherapy
Abstract
Effective anticancer therapies typically activate antitumour immunity, predominately mediated by T cells in the tumour microenvironment. Here, we discuss the roles of B cells and tertiary lymphoid structures in the context of chemotherapy-induced complement activation, which results in the induction of a B cell subset that modulates T cell function.
Fichier principal
Sautès-Fridman et Roumenina - 2020 - B cells and complement at the forefront of chemoth.pdf (108.85 Ko)
Télécharger le fichier
Fig NRCO finale.pdf (174.02 Ko)
Télécharger le fichier
| Origin | Files produced by the author(s) |
|---|